Dapagliflozin: All-Cause & Cardiovascular Mortality
Research has shown the beneficial effects of empagliflozin on all-cause and CV mortality. Does the same hold true for another SGLT2 inhibitor?
Combo Therapy vs Insulin: Type 2 Diabetes
The Qatar Study investigated the efficacy of exenatide plus pioglitazone versus basal-bolus insulin in poorly-controlled type 2 diabetes.
Type 1 Diabetes and the Microbiome
The authors compared biopsies of the duodenal mucosa in patients with type 1 diabetes, celiac disease, and controls.
Thyroid Dysfunction: Relation to Radiation Dose
Researchers examined the correlation between radiation dose for head and neck cancer and subsequent thyroid dysfunction.
Diabetes & Ethnicity: Potential Life Years Lost
What role, if any, does ethnicity play in potential life years lost in patients with diabetes?
Psilocybin to Manage Cancer-Related Depression
Dr. Bobby Lazzara reviews a small study testing the effects of psilocybin on depression and anxiety in patients with life-threatening cancer.
Diabetes Incidence: State-by-State
The incidence of diabetes in the US continues to grow – 11.5% in 2016. Dr. Lazzara looks at a state-by-state breakdown.
By clicking Accept, you agree to become a member of the UBM Medica Community.